Abstract:Since its initial discovery as the basis for nicotinic acetylcholine receptor ligands, the 3-alkoxyisoxazole scaffold has been shown to be a versatile platform for the development of potent sigma 1 and sigma 2 receptor ligands. Herein we report a further SAR exploration of the 3-alkoxyisoxazole scaffold with the aim of obtaining potent sigma 2 receptor ligands. Various substitutions on the benzene ring and at the basic amino regions resulted in a total of 21 compounds that were tested for their binding affinities for the sigma 2 receptor. In particular, compound 51 [(2S)-1-(4-ammoniobutyl)-2-(((5-((3,4-dichlorophenoxy)methyl)isoxazol-3-yl)oxy)methyl)pyrrolidin-1-ium chloride] was identified as one of the most potent sigma 2 ligands within the series, with a K-i value of 7.9 nM. It demonstrated potent antiproliferative effects on both osteosarcoma cell lines 143B and MOS-J (IC50 values of 0.89 and 0.71 mu M, respectively), relative to siramesine (IC50 values of 1.81 and 2.01 mu M). Moreover, compound 51 inhibited clonal formation of osteosarcoma 143B cells at 1 mu M, corresponding to half the dose required of siramesine for similar effects. The general cytotoxicity profile of compound 51 was assessed in a number of normal cell lines, including HaCaT, HAF, and LO2 cells. Furthermore, FACS analysis showed that compound 51 likely inhibits osteosarcoma cell growth by disruption of the cell cycle and promotion of apoptosis.

Anti-osteosarcoma Effect of Novel Pyran-Annulated Heterocycles Derivatives

Antitumor Activities of Pyran-Annulated Heterocycles

Synthesis and Anticancer Study of Novel 4H-Chromen Derivatives

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Novel Pyran Derivatives: Inhibiting Human Non-Small Cell Lung Cancer Growth

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis and Pharmacological Evaluation of 2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma

Design, synthesis and anti-osteosarcoma activity study of novel pyrido[2,3-d]pyrimidine derivatives by inhibiting DKK1-Wnt/β-catenin pathway

Synthesis and Antiproliferative Activitiy of Novel Diaryl Ureas Possessing a 4<i>H-</i>Pyrido[1,2-<i>a</i>]pyrimidin-4-one Group

Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.

Novel 4-Hydroxycoumarin Derivatives: Anti-Cancer Effects on Human Oral Cancer Cells

Synthesis and discovery of novel pyrazole carboxamide derivatives as potential osteogenesis inducers.

Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.

Biological Evaluation and Docking Studies of Biscoumarin Derivatives as Anticancer Agents on Human Osteogenic Sarcoma Cells

Novel 4-Arylpolyhydroquinoline Derivatives: Synthesis and Inhibition of Human Cervical Cancer Cells

Synthesis and Antitumor Activities of Novel Pyrimidine-fused Spiropyrrolidine Oxindoles

Design, synthesis and anticancer activity of novel steroidal derivatives with D‐ring fused or substituted N‐heterocyclic systems

Synthesis, Docking and Biological Evaluation of Isoquinolonic Acid Derivatives

Novel Naphthol Derivatives: Synthesis, Docking Studies and Inhibiting Human Glioma Cells

Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.